Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2018

Ausgabe 1/2018

Inhaltsverzeichnis ( 30 Artikel )

06.12.2017 | Review | Ausgabe 1/2018 Open Access

Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes

José H. Volders, Vera L. Negenborn, Pauline E. Spronk, Nicole M. A. Krekel, Linda J. Schoonmade, Sybren Meijer, Isabel T. Rubio, M. Petrousjka van den Tol

11.01.2018 | Correction | Ausgabe 1/2018

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes

José H. Volders, Vera L. Negenborn, Pauline E. Spronk, Nicole M. A. Krekel, Linda J. Schoonmade, Sybren Meijer, Isabel T. Rubio, M. Petrousjka van den Tol

11.11.2017 | Preclinical study | Ausgabe 1/2018 Open Access

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer

Josefine Bostner, Anya Alayev, Adi Y. Berman, Tommy Fornander, Bo Nordenskjöld, Marina K. Holz, Olle Stål

11.12.2017 | Preclinical study | Ausgabe 1/2018

Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results

Kamaljeet Singh, Xin He, Elizabeth T. Kalife, Shahrzad Ehdaivand, Yihong Wang, C. James Sung

08.11.2017 | Clinical trial | Ausgabe 1/2018

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

Filipa Lynce, Matthew J. Blackburn, Ling Cai, Heping Wang, Larry Rubinstein, Pamela Harris, Claudine Isaacs, Paula R. Pohlmann

09.11.2017 | Clinical trial | Ausgabe 1/2018

Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer

K. A. Nyrop, A. M. Deal, S. K. Choi, C. W. Wagoner, J. T. Lee, A. Wood, C. Anders, L. A. Carey, E. C. Dees, T. A. Jolly, K. E. Reeder-Hayes, H. B. Muss

09.11.2017 | Clinical trial | Ausgabe 1/2018

Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer

Maryann Kwa, Xiaochun Li, Yelena Novik, Ruth Oratz, Komal Jhaveri, Jennifer Wu, Ping Gu, Marleen Meyers, Franco Muggia, James Speyer, Alyssa Iwano, Maryam Bonakdar, Lina Kozhaya, Ece Tavukcuoglu, Bahar Budan, Roy Raad, Judith D. Goldberg, Derya Unutmaz, Sylvia Adams

11.11.2017 | Clinical trial | Ausgabe 1/2018

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology

Eleftherios P. Mamounas, Gong Tang, Soonmyung Paik, Frederick L. Baehner, Qing Liu, Jong-Hyeon Jeong, S. Rim Kim, Steven M. Butler, Farid Jamshidian, Diana B. Cherbavaz, Amy P. Sing, Steven Shak, Thomas B. Julian, Barry C. Lembersky, D. Lawrence Wickerham, Joseph P. Costantino, Norman Wolmark

14.11.2017 | Clinical trial | Ausgabe 1/2018 Open Access

Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial

Sara Mijwel, Malin Backman, Kate A. Bolam, Anna Jervaeus, Carl Johan Sundberg, Sara Margolin, Maria Browall, Helene Rundqvist, Yvonne Wengström

17.11.2017 | Clinical trial | Ausgabe 1/2018

Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer

Hánah N. Rier, Agnes Jager, Stefan Sleijfer, Joost van Rosmalen, Marc C. J. M. Kock, Mark-David Levin

20.11.2017 | Clinical trial | Ausgabe 1/2018

Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up

Karama Asleh, Jennifer R. Won, Dongxia Gao, K. David Voduc, Torsten O. Nielsen

21.11.2017 | Clinical trial | Ausgabe 1/2018 Open Access

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer

Martin P. Nilsson, Therese Törngren, Karin Henriksson, Ulf Kristoffersson, Anders Kvist, Barbro Silfverberg, Åke Borg, Niklas Loman

21.11.2017 | Clinical trial | Ausgabe 1/2018 Open Access

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial

Joyce O’Shaughnessy, Katarina Petrakova, Gabe S. Sonke, Pierfranco Conte, Carlos L. Arteaga, David A. Cameron, Lowell L. Hart, Cristian Villanueva, Erik Jakobsen, Joseph T. Beck, Deborah Lindquist, Farida Souami, Shoubhik Mondal, Caroline Germa, Gabriel N. Hortobagyi

22.11.2017 | Clinical trial | Ausgabe 1/2018

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers

Takahiro Watanabe, Akira I. Hida, Natsuko Inoue, Michiko Imamura, Yukie Fujimoto, Kouhei Akazawa, Seiichi Hirota, Yasuo Miyoshi

22.11.2017 | Clinical trial | Ausgabe 1/2018

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Christina M. Dieli-Conwright, Jean-Hugues Parmentier, Nathalie Sami, Kyuwan Lee, Darcy Spicer, Wendy J. Mack, Fred Sattler, Steven D. Mittelman

24.11.2017 | Clinical trial | Ausgabe 1/2018 Open Access

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Rossanna C. Pezo, Tom W. Chen, Hal K. Berman, Anna M. Mulligan, Albiruni A. Razak, Lillian L. Siu, David W. Cescon, Eitan Amir, Christine Elser, David G. Warr, Srikala S. Sridhar, Celeste Yu, Lisa Wang, Tracy L. Stockley, Suzanne Kamel-Reid, Philippe L. Bedard

24.11.2017 | Clinical trial | Ausgabe 1/2018 Open Access

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

M. C. U. Cheang, J. M. Bliss, G. Viale, V. Speirs, C. Palmieri, A. Shaaban, P. E. Lønning, J. Morden, N. Porta, J. Jassem, C. J. van De Velde, B. B. Rasmussen, D. Verhoeven, J. M. S. Bartlett, R. C. Coombes, On Behalf of the PathIES Sub-Committee

25.11.2017 | Clinical trial | Ausgabe 1/2018

Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer

S. L. Villegas, S. Darb-Esfahani, G. von Minckwitz, J. Huober, K. Weber, F. Marmé, J. Furlanetto, C. Schem, B. M. Pfitzner, B. Lederer, K. Engels, S. Kümmel, V. Müller, K. Mehta, C. Denkert, S. Loibl

20.11.2017 | Epidemiology | Ausgabe 1/2018

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study

O. Brouckaert, K. Van Asten, A. Laenen, A. Soubry, A. Smeets, I. Nevelstreen, I. Vergote, H. Wildiers, R. Paridaens, E. Van Limbergen, C. Weltens, P. Moerman, G. Floris, P. Neven, On behalf of Multidisciplinary breast centre Leuven

23.11.2017 | Epidemiology | Ausgabe 1/2018 Open Access

Real-world treatment in patients with HER2+ metastatic breast cancer

Treatment decisions in HER2+ mBC
R. Colomer, P. Hall, M. Szkultecka-Debek, R. C. Bondi, A. Flinois, S. Auziere, J. Y. Le Cléac’h

27.11.2017 | Epidemiology | Ausgabe 1/2018

Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results

David J. Press, Abiola Ibraheem, M. Eileen Dolan, Kathleen H. Goss, Suzanne Conzen, Dezheng Huo

27.11.2017 | Epidemiology | Ausgabe 1/2018

Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse

Caroline Lohrisch, Mia Francl, Sophie Sun, Diego Villa, Karen A. Gelmon

28.11.2017 | Epidemiology | Ausgabe 1/2018

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening

Amy Trentham-Dietz, Mehmet Ali Ergun, Oguzhan Alagoz, Natasha K. Stout, Ronald E. Gangnon, John M. Hampton, Kim Dittus, Ted A. James, Pamela M. Vacek, Sally D. Herschorn, Elizabeth S. Burnside, Anna N. A. Tosteson, Donald L. Weaver, Brian L. Sprague

10.11.2017 | Brief Report | Ausgabe 1/2018

Body mass index, diet, and exercise: testing possible linkages to breast cancer risk via DNA methylation

Arielle S. Gillman, Casey K. Gardiner, Claire E. Koljack, Angela D. Bryan

11.11.2017 | Brief Report | Ausgabe 1/2018 Open Access

Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer

Andrew Dodson, David Okonji, Laura Assersohn, Anne Rigg, Amna Sheri, Nick Turner, Ian Smith, Marina Parton, Mitch Dowsett

11.11.2017 | Brief Report | Ausgabe 1/2018 Open Access

Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot

Karen Meneses, Rachel Benz, Jennifer R. Bail, Jacqueline B. Vo, Kristen Triebel, Pariya Fazeli, Jennifer Frank, David E. Vance

15.11.2017 | Brief Report | Ausgabe 1/2018

Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting

Omar Abdel-Rahman

22.11.2017 | Brief Report | Ausgabe 1/2018

Are VNTRs co-localizing with breast cancer-associated SNPs?

Martin Leclerc, Susan L. Neuhausen, Hagit Schayek, Yael Laitman, Antoniou C. Antonis, Eitan Friedman

24.11.2017 | Letter to the Editor | Ausgabe 1/2018

Does tacrolimus have any positive impact on outcome of post-transplant breast cancer patients?

Kadri Altundag

24.11.2017 | Letter to the Editor | Ausgabe 1/2018

Obesity’s impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer

Ying L. Liu, Eileen P. Connolly, Kevin Kalinsky

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise